Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 55–90 · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Phase 3
- Target enrollment
- 1000
- US sites recruiting
- 57
- Study start
- July 11, 2023
- Record last updated
- October 16, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a Phase 3 global, multicenter, 52-week, open-label extension (OLE) rollover study for subjects completing study CN012-0026, CN012-0027 or CN012-0056. Subjects (randomized or non-randomized) who complete the 38-week CN012-0026 study, 14-week CN012-0027 study or 14-week CN012-0056 study will be eligible to enroll in CN012-0028. The primary objective of the study is to assess the long-term safety and tolerability of KarXT in subjects with psychosis associated with Alzheimer's Disease.
Being studied: KarXT
Conditions: Psychosis Associated With Alzheimer's Disease
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Must have completed study KAR-031 (CN012-0026), KAR-032(CN012-0027), or CN012-0056. This Inclusion criterion is not applicable for Protocol Amendment 07 or later versions.
- Can understand the nature of the study and protocol requirements and provide a signed informed consent (IC) form before any study assessments are performed. If the subject is deemed not competent to provide IC, both the following requirements for consent must be met:
- The subject's legally acceptable representative (LAR) must provide IC
- The subject must provide informed assent
- Must have stable living environment. At entry into this study, or any time during the study, if a subject needs to relocate from home, a residential assisted-living facility, or other stable location to a nursing home facility, the Sponsor/Medical Monitor must approve the subject's participation in the study.
Exclusion Criteria
- Significant or severe medical conditions that, in the opinion of the Investigator, could jeopardize the safety of the subject, ability to complete or comply with the study procedures or validity of the study results.
- Clinically significant abnormalities, including any finding(s) from the ECG, laboratory tests, physical examination, or vital signs, at the EOT visit of Study KAR-031 (Visit 19), Study KAR-032 (Visit 12), Study CN012-0056 (Visit 12) that the Investigator, in consultation with the Medical Monitor, are considered to jeopardize the safety of the subject.
- Subjects participating in another investigational drug or device study or planning on participating in another clinical study during the duration of KAR-033.
- Other protocol-defined Inclusion/Exclusion criteria apply.
Recruiting US locations
Advanced Research Center, Inc.
Anaheim, CA 92805-5854
Site contact: Steven Macina, Site 1104 · 714-999-6688
USC - The Memory and Aging Center (MAC) - Alzheimer Disease Research Center (ADRC)
Los Angeles, CA 90033-5313
Site contact: Lon Schneider, Site 1226 · 323-442-3715
SC3 Research - Pasadena - 960 E. Green St
Pasadena, CA 91106
Site contact: M. Lorraine Purino, Site 1043 · 626-250-2070
Sunwise Clinical Research, LLC - Walnut Creek - IVY - PPDS
Walnut Creek, CA 94596
Site contact: Ira Glick, Site 1007 · 925-298-5147
University of Connecticut Health Center
Farmington, CT 06030
Site contact: Neha Jain, Site 1222 · 860-790-7354
Envision Trials LLC
Bonita Springs, FL 34134
Site contact: Daniel Mandri, Site 1020 · 305-819-2909
K2 Medical Research - Winter Garden
Clermont, FL 34711-5933
Site contact: Christopher Galloway, Site 1048 · 321-500-5252
JY Research Institute Inc
Cutler Bay, FL 33189-1230
Site contact: Suez Oramas Mingo, Site 1138 · 305-424-8696
Arrow Clinical Trials
Daytona Beach, FL 32117-5532
Site contact: David Billmeier, Site 1023 · 386-278-8000
Integrity Clinical Research LLC - 21st Street
Doral, FL 33122-1620
Site contact: Lucinda Cuervo-Ramos, Site 1164 · 305-888-0410
Betancourt Research Services
Doral, FL 33172-2638
Site contact: Beatriz Triana, Site 1045 · 786-741-2287
Direct Helpers Research Center
Hialeah, FL 33012-3618
Site contact: Manuel Fernandez, Site 1107 · 305-828-3555
New Life Medical Research Center -3750 W 16th Ave
Hialeah, FL 33012-4648
Site contact: Jorge Betancourt, Site 1120 · 305-456-7782
Las Mercedes Medical Research - 4440 West 16th Ave
Hialeah, FL 33012
Site contact: Frank Carlos Alvarez Li, Site 1052 · 786-334-6675
Galiz Research
Hialeah, FL 33016-1814
Site contact: Jose Gamez, Site 1140 · 305-805-0921
Nexus Clinical Research Center- NRC
Homestead, FL 33030
Site contact: John Cintron, Site 1229
Coral Clinic Research
Homestead, FL 33032
Site contact: Nelson Gonzalez, Site 1049 · 786-715-2200
Homestead Associates in Research Inc-30328 Old Dixie Hwy
Homestead, FL 33033
Site contact: Angel Carrasco, Site 1159 · 786-422-7374
K2 Medical Research - Maitland
Maitland, FL 32751-5669
Site contact: Brandon Lenox, Site 1039 · 407-670-5833
Premier Clinical Research Institute
Miami, FL 33122-1335
Site contact: Emelina Arocha, Site 1021 · 305-445-5994
Angels Clinical Research Institute - Miami
Miami, FL 33122-1721
Site contact: Yanely Pineiro Puebla, Site 1118 · 786-218-1733
CCM Clinical Research Group
Miami, FL 33133-4231
Site contact: Francisco Ricart, Site 1108 · 208-346-8900
Wellness Research Center Inc - Miami
Miami, FL 33135-1601
Site contact: Brian Villa, Site 1125 · 786-238-7099
A & D Doctor Center
Miami, FL 33135-2968
Site contact: Yordan Orive Gomez, Site 1236 · 305-223-2000
Floridian Neuroscience Institute-1901 SW 1 St
Miami, FL 33135
Site contact: Emilio Mantero-Atienza, Site 1115 · 305-326-0776
MedOne Clinical Research LLC
Miami, FL 33145-2455
Site contact: Thierry Jacquemin, Site 1143 · 305-359-7666
Allied Biomedical Research Institute
Miami, FL 33155-4630
Site contact: Michael Pfeffer, Site 1009 · 866-879-2507
My Community Research Center, Inc - 7480 Bird Rd
Miami, FL 33155-6630
Site contact: Cesar Guerrero, Site 1113 · 786-359-4867
Future Care Solution LLC
Miami, FL 33165-3947
Site contact: Pilar Trueba, Site 1129 · 305-888-0410
Reliant Medical Research
Miami, FL 33165
Site contact: Carlos Ramirez Calderon, Site 1150 · 786-801-0912
South Florida Research Phase I-IV, Inc. - Miami
Miami, FL 33166
Site contact: Silvia Silva Duluc, Site 1053 · 305-669-6166
Novel Clinical Research Center, LLC -7000 SW 97th Ave
Miami, FL 33173-1474
Site contact: Heber Varela, Site 1006 · 000-000-0000
Dade Research Center - Miami FL - 7600 SW 87th Ave
Miami, FL 33173
Site contact: Maria Nualart, Site 1111 · 305-263-7120
Florida Research Center, Inc.
Miami, FL 33174-2950
Site contact: Sonia Rente, Site 1109 · 305-551-8493
Serenity Research Center
Miami, FL 33176-1451
Site contact: Sergio Jaramillo, Site 1235 · 305-596-2080
IMIC LLC- 9380 SW 150th Str
Miami, FL 33176-7947
Site contact: Leon Ramon, Site 1147 · 786-600-7005
New Gen Health
Miami, FL 33176
Site contact: Roberto Hernando, Site 1234 · 305-892-1035
High Quality Research
Miami, FL 33184-1412
Site contact: Jorge Gonzalez, Site 1157 · 305-392-0244
Coral Research Clinic & Coral Diagnostic Center
Miami, FL 33186-4643
Site contact: Jorge Paoli Bruno, Site 1054 · 000-000-0000
ONHEALTH Research Center
Miami, FL 33186-5882
Site contact: Maria Rodil, Site 1042 · 786-808-0832
New Med Research
Miami Gardens, FL 33056-4000
Site contact: Marta Fernandez, Site 1126 · 305-269-7100
San Marcus Research Clinic Inc
Miami Lakes, FL 33014-5602
Site contact: Nancy Navarro Gonzalez, Site 1032
Meridian International Research
Miami Lakes, FL 33014-6435
Site contact: Gonzalo Quesada, Site 1102 · 305-705-4494
Ocean Blue Medical Research Center Inc
Miami Springs, FL 33166-5260
Site contact: Antonio Terrelonge, Site 1026 · 305-885-8983
Nova Psychiatry
Orlando, FL 32803
Site contact: David Medina, Site 1242 · 407-823-8421
Combined Research Orlando Phase I-IV LLC
Orlando, FL 32807-3555
Site contact: Eric Carbonell, Site 1112 · 407-440-4493
Neurology Associates of Ormond Beach
Ormond Beach, FL 32174-3101
Site contact: David McDonald, Site 1204 · 386-673-2500
Angels Clinical Research Institute Tampa - Palm Springs - PPDS
Tampa, FL 33614-2869
Site contact: Al Robaina, Site 1123 · 813-931-0128
Guardian Angel Research
Tampa, FL 33614
Site contact: Sadaf Bazargan, Site 1124 · 813-300-3300
Interventional Psychiatry of Tampa Bay
Tampa, FL 33629-5837
Site contact: Jamie Fernandez, Site 1110 · 813-251-1800
Premiere Research Institute at Palm Beach Neurology, PA
West Palm Beach, FL 33407-3209
Site contact: Paul Winner, Site 1216 · 561-845-0500
Agile Clinical Research Trials, LLC
Atlanta, GA 30328-5532
Site contact: Vasundhara Cheekati, Site 1206 · 404-382-8660
Precise Research Centers
Flowood, MS 39232
Site contact: Joseph Kwentus, Site 1132 · 601-420-5810
Five Towns Neurology PC -Woodmere - 923 Broadway
Woodmere, NY 11598-1739
Site contact: David Steiner, Site 1025 · 516-239-1800
AMC Research, LLC - Flourish - PPDS
Matthews, NC 28105-8336
Site contact: Mohammad Bolouri, Site 1214 · 704-364-4000
Horizon Clinical Research: Gill Neuroscience
Cypress, TX 77429-6070
Site contact: Harpaul Gill, Site 1106 · 949-491-0710
Clinical Trial Network - 7080 Southwest Fwy
Houston, TX 77074-2085
Site contact: Djamchid Lotfi, Site 1004 · 713-484-6947
Study contacts (from the official record)
- BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
- First line of the email MUST contain NCT # and Site #.
Similar studies in California
All mental health studies in California →- RecruitingHealthy volunteersEarly Phase 1
Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable Schizophrenia
Neurosterix
- Location
- Los Alamitos, CA
- Eligibility basics
- Ages 18–55
- RecruitingPhase 1Overnight stay mentioned
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
Leal Therapeutics, Inc
- Location
- Los Alamitos, CA + 9 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingPhase 1Overnight stay mentioned
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
BioXcel Therapeutics Inc
- Location
- Anaheim, CA + 3 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingHealthy volunteersPhase 1
Inflammatory Challenge and Fear
University of California, San Francisco
- Location
- San Francisco, CA
- Eligibility basics
- Ages 18–65